Leukemia microvesicles affect healthy hematopoietic stem cells

Tumor Biology

Volumn 39, Issue 2, 2017, Pages

  Razmkhah, Farnaz ^a   Soleimani, Masoud ^a   Mehrabani, Davood ^b   Karimi, Mohammad Hossein ^c   Amini Kafi abad, Sedigheh ^d   Ramzi, Mani ^e   Iravani Saadi, Mahdiyar ^b,c   Kakoui, Javad ^f  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d HIGH INSTITUTE FOR RESEARCH AND EDUCATION IN TRANSFUSION MEDICINE   (Iran)

^e SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f Atieh Hospital Tehran   (Iran)

Author keywords

hematopoietic stem cell; leukemia; Microvesicles; transformation

Indexed keywords

CD34 ANTIGEN; CD8 ANTIGEN; MICRORNA 21; MICRORNA 29A; STEM CELL FACTOR RECEPTOR; THY 1 ANTIGEN;

ACUTE MYELOID LEUKEMIA; ADULT; AGED; ARTICLE; CANCER PATIENT; CELL COUNT; CELL DIFFERENTIATION; CELL ISOLATION; CELL SPECIFICITY; CELL SURVIVAL; CELLULAR PARAMETERS; COCULTURE; COLONY FORMATION; COLONY FORMING UNIT; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE TRANSFER; GENETIC TRAIT; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; INCUBATION TIME; LEUKEMIA CELL; MALE; MEMBRANE MICROPARTICLE; MICRORNA-21 GENE; MICRORNA-29A GENE; MIDDLE AGED; PHENOTYPE; PRIORITY JOURNAL; UMBILICAL CORD BLOOD CELL; BONE MARROW CELL; CASE CONTROL STUDY; CYTOLOGY; FETUS BLOOD; PATHOLOGY;

AGED; BONE MARROW CELLS; CASE-CONTROL STUDIES; CELL-DERIVED MICROPARTICLES; FEMALE; FETAL BLOOD; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED;

EID: 85014849155     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1177/1010428317692234     Document Type: Article

References (22)

1. Muralidharan-Chari V, Clancy JW, Sedgwick A. Microvesicles: mediators of extracellular communication during cancer progression. J Cell Sci 2010; 123: 1603–1611.
2. Schorey JS, Bhatnagar S. Exosome function: from tumor immunology to pathogen biology. Traffic 2008; 9: 871–881.
3. Morel O, Toti F, Hugel B. Cellular microparticles: a disseminated storage pool of bioactive vascular effectors. Curr Opin Hematol 2004; 11: 156–164.
4. Aliotta JM, Pereira M, Johnson KW. Microvesicle entry into marrow cells mediates tissue-specific changes in mRNA by direct delivery of mRNA and induction of transcription. Exp Hematol 2010; 38: 233–245.
5. Baj-Krzyworzeka M, Szatanek R, Weglarczyk K. Tumor-derived microvesicles carry several surface determinants and mRNA of tumor cells and transfer some of these determinants to monocytes. Cancer Immunol Immunother 2006; 55: 808–818.
6. Zernecke A, Bidzhekov K, Noels H. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2009; 2: ra81.
7. Théry C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009; 9: 581–593.
8. Quesenberry PJ, Aliotta JM. Cellular phenotype switching and microvesicles. Adv Drug Deliv Rev 2010; 62: 1141–1148.
9. Ratajczak J, Miekus K, Kucia M. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 2006; 20: 847–856.
10. Ferrara F, Schiffer CA. Acute myeloid leukemia in adults. Lancet 2013; 381(9865): 484–495.
11. Hasserjian RP. Acute myeloid leukemia: advances in diagnosis and classification. Int J Lab Hematol 2013; 35: 358–366.
12. Chung SS, Hu W, Park CY. The role of MicroRNAs in hematopoietic stem cell and leukemic stem cell function. Ther Adv Hematol 2011; 2(5): 317–334.
13. Zhang L, Valencia CA, Dong B. Transfer of microRNAs by extracellular membrane microvesicles: a nascent crosstalk model in tumor pathogenesis, especially tumor cell-microenvironment interactions. J Hematol Oncol 2015; 22(8): 14.
14. Mohammadi-Yeganeh S, Paryan M, Mirab Samiee S. Development of a robust, low cost stem-loop real-time quantification PCR technique for miRNA expression analysis. Mol Biol Rep 2013; 40(5): 3665–3674.
15. Razmkhah F, Soleimani M, Mehrabani D. Leukemia cell microvesicles promote survival in umbilical cord blood hematopoietic stem cells. EXCLI J 2015; 14: 423–429.
16. Buscaglia LE, Li Y. Apoptosis and the target genes of microRNA-21. Chin J Cancer 2011; 30(6): 371–380.
17. Fulci V, Chiaretti S, Goldoni M. Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood 2007; 109: 4944–4951.
18. Lawrie CH, Soneji S, Marafioti T. MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int J Cancer 2007; 121: 156–161.
19. Pichiorri F, Suh SS, Ladetto M. MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proc Natl Acad Sci USA 2008; 105: 12885–12890.
20. Leeuw DC. MicroRNA expression profiling of hematopoietic and leukemic stem cells in acute myeloid leukemia. In: 53rd ASH annual meeting and exposition, San Diego, CA, 10–13 December 2011.
21. Velu CS, chaubey A, Phelan JD. Therapeutic antagonists of microRNAs deplete leukemia-initiating cell activity. J Clin Invest 2014; 124: 222–236.
22. Han YC, Park CY, Bhagat G. MicroRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development and acute myeloid leukemia. J Exp Med 2010; 207: 475–489.